Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications association between tumor necrosis factor inhibitor tnfi therapy changes c reactive
… research, there are important conceptual differences between these terms that writers should be aware of in their … and Editing at the national American Medical Writers Association (AMWA) conference in Denver on Nov. 5. Staff …
… prevention. These new studies were conducted because of changes in disease epidemiology, vaccine uptake, and evolving … these links. Talbird SE , Carrico J , La EM, Carias C, Marshall GS, Roberts CS, Chen YT, Nyaku MK. Impact of … Carrico J , La EM, Talbird SE , Chen YT, Nyaku MK, Carias C, Mellott CE, Marshall GS, Roberts C. Value of the …
2023 Annual Conference on Vaccinology Research Share on: Monday, June 5 - Wednesday, June 7, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the 2023 Annual Conference on Vaccinology Research. Disparities …
Infectious Disease Models Utilize the power of infectious disease models to inform your analyses and help you better understand the potential impact of your novel healthcare intervention. You rely on realistic disease models to understand and communicate …
RTI Releases 2023 Corporate Responsibility and Sustainability Report Share on: February 7, 2024 Institute commits additional $9 million to internal sustainability investments to reduce GHG emissions RTI International, a nonprofit research institute, has …
… outcomes in unresectable stage III epidermal growth factor receptor-mutation positive (EGFRm) non-small cell lung … (RW) study. Neal J, Lee JB, Ahn MJ, Ariyasu R, Nash C, Smith D, Nagar S, Jimenez M , Kahangire DA, Kim YJ, …
… including regulatory submissions, reports, and publications Support to secure regulatory acceptability of …
Collaborative Regulatory RWE Research Through our Barcelona based team, we are a partner center of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) which is led by the European Medicines Agency. We are dedicated to …
… analysis of the long-term effect of Tolvaptan in patients between 56 and 65 years with Autosomal Dominant Polycystic …
… stop by our posters and see our research on Avelumab therapy and Fetal and neonatal alloimmune thrombocytopenia. … CT April 16, 2024 Avelumab first-line maintenance (1LM) therapy for locally advanced/metastatic urothelial carcinoma … Grivas P, Barata P, Moon H, Gupta S, Hutson T, Sternberg C, Brown J, Dave V, Downey C, Shillington A, Katzenstein H, …